Locally Recurrent Skin Squamous Cell Carcinoma
Oncology
3 drugs in development·2 companies·1 clinical trial
Drug Pipeline by Phase
Phase 3(1)
| Drug | Company |
|---|---|
| Cetuximab | FATE THERAPEUTICS INC (FATE) |
Compare drugs
Frequently asked questions
How many drugs are in development for Locally Recurrent Skin Squamous Cell Carcinoma?
BioSniper tracks 3 drugs in development for Locally Recurrent Skin Squamous Cell Carcinoma across 2 companies.
How many clinical trials target Locally Recurrent Skin Squamous Cell Carcinoma?
There are 1 clinical trial targeting Locally Recurrent Skin Squamous Cell Carcinoma tracked by BioSniper.
Deep-dive into Locally Recurrent Skin Squamous Cell Carcinoma
Full trial data, competitive analysis, and AI-powered pipeline tracking.
Start Free Analysis